Benjamin F. Edwards & Company, Inc. Cidara Therapeutics, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.85 - $4.1 $17,521 - $25,206	-6,148 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$1.74 - $4.26 $1,997 - $4,890	1,148 Added 22.96%	6,148 $15,000
Q2 2019 Aug 08, 2019	BUY	$1.49 - $2.94 $7,450 - $14,700	5,000 New	5,000 $8,000

6.22K

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $7.66B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.